The Potential Neuroprotection Mechanism of GDNF in the 6-OHDA-Induced Cellular Models of Parkinson’s Disease

By Li Feng   Wang Meng   Zhu Shuan   Li Li   Xiong Ye   Gao Dian-Shuai  

Cellular and Molecular Neurobiology, Vol. 33, Iss. 7, 2013-10 ,pp. : 907-919

Springer Publishing Company

Access to resources Recommend Favorite

Delivery of a GDNF Gene into the Substantia Nigra after a Progressive 6-OHDA Lesion Maintains Functional Nigrostriatal Connections

By Kozlowski D.A.   Connor B.   Tillerson J.L.   Schallert T.   Bohn M.C.  

Experimental Neurology, Vol. 166, Iss. 1, 2000-11 ,pp. : 1-15

Elsevier

Access to resources Recommend Favorite

Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies

By Chaturvedi R.K.   Agrawal A.K.   Seth K.   Shukla S.   Chauhan S.   Shukla Y.   Sinha C.   Seth P.K.  

International Journal of Developmental Neuroscience, Vol. 21, Iss. 7, 2003-11 ,pp. : 391-400

Elsevier

Access to resources Recommend Favorite

Reversal of dyskinesias in an animal model of Parkinson's disease by continuous l -DOPA delivery using rAAV vectors

By Carlsson Thomas  

Brain, Vol. 128, Iss. 3, 2005-03 ,pp. : 559-569

Oxford University Press

Access to resources Recommend Favorite

The coming of age of the GDNF family and its receptors: gene delivery in a rat Parkinson model may have clinical implications

By Olson L.  

Trends in Neurosciences, Vol. 20, Iss. 7, 1997-07 ,pp. : 277-279

Elsevier

Access to resources Recommend Favorite